Ketamine for posttraumatic stress disorder--reply

Affiliations

¹ Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
² Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York2Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York3Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New Y.

Comment

Adriana Feder et al. JAMA Psychiatry. 2015 Jan.

. 2015 Jan;72(1):95-6.

doi: 10.1001/jamapsychiatry.2014.1751.

¹ Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
² Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York2Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York3Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New Y.

No abstract available

Comment on

Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het Rot M, Lapidus KA, Wan LB, Iosifescu D, Charney DS. Feder A, et al. JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62. JAMA Psychiatry. 2014. PMID: 24740528 Clinical Trial.
Ketamine for posttraumatic stress disorder.
Rasmussen KG. Rasmussen KG. JAMA Psychiatry. 2015 Jan;72(1):94-5. doi: 10.1001/jamapsychiatry.2014.1621. JAMA Psychiatry. 2015. PMID: 25564790 No abstract available.